LSBio
IHC-plus™ BCL2L10 / Diva Antibody

Anti-BCL2L10 / BCL-B antibody IHC of human brain, cortex. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.

IHC-plus™ BCL2L10 / Diva Antibody

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunocytochemistry, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human
Format:Liquid
See all BCL2L10 / Diva antibodies →
$383.00each
Catalog Number: LS-B452-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
Diva antibody LS-B452 is an unconjugated rabbit polyclonal antibody to human Diva (BCL2L10). Validated for ELISA, ICC, IHC and WB. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
Application
ELISA, ICC, IHC, IHC-P, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This product carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
BCL-B | Apoptosis regulator Bcl-B | BCL2L10 | BCLB | Bcl2-L-10 | Diva not vaccine | Anti-apoptotic protein NrH | Bcl-2-like protein 10 | Boo | Boo not bladder | Diva
Recommended Dilution: IHC-P
5 µg/ml
Recommended Dilution: WB
1 - 2 µg/ml
UniProt Number
Q9HD36
SwissProt
Q9HD36

Target

Target
BCL2L10 / Diva
Antigen Species
Human
Gene Name
BCL2L10

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Origin Species
Human

Immunogen

Immunogen
A 16 AA synthetic peptide near the N-Terminus of human Bcl-B. The immunogen is located within aa 90-140 of Bcl-B.
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS containing 0.02% Sodium Azide
Concentration
1 mg/mL
Animal Free
No
Carrier-Free
Yes
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at 4°C for up 3 months. Store at -20°C for up to 1 year. Avoid freeze/thaw cycles.
Recommended Storage Buffer
PBS
Loss of BCL2L10 protein expression as prognostic predictor for poor clinical outcome in gastric carcinoma. Xu JD, Furuya T, Cao XX, Liu XL, Li QQ, Wang WJ, Xu JW, Xu ZD, Sasaki K, Liu XP. Histopathology. 2010 Dec;57:814-24. PubMed: 21166696

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.